[在达沙替尼治疗下发生的全发性链球菌毒性休克综合征]
Miku Saito1, Yusuke Wada1, Ai Takahashi1
1Izumi City General Hospital Hematology/Nephrology.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|November 5, 2025
概括
这项研究报告了两例链球菌毒性休克综合征 (STSS) 在慢性髓性白血病 (CML) 用达沙替尼治疗的患者中. 这些发现表明达沙替尼治疗与CML患者中STSS的发展之间存在潜在的联系.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 传染性疾病 传染性疾病
背景情况:
- 慢性髓性白血病 (CML) 是一种骨髓增殖性瘤.
- 达沙替尼 (Dasatinib) 是一种用于CML治疗的氨酸激酶抑制剂.
- 链球菌毒性休克综合征 (STSS) 是一种严重的,危及生命的疾病.
研究的目的:
- 调查CML患者的达沙替尼治疗和STSS之间的潜在关联.
- 在患有STSS的患者中审查CML治疗选择.
主要方法:
- 关于两名CML患者的病例报告,他们在服用达沙替尼的同时发展出STSS.
- 关于CML治疗和STSS的文献综述.
主要成果:
- 两名用达沙替尼布治疗的CML患者出现了STSS.
- 患者1在达沙替尼的剂量减少后经历了STSS.
- 患者2在达沙替尼治疗后实现深度分子缓解后出现了STSS.
结论:
- 在CML患者中,达沙替尼治疗可能与STSS风险增加有关.
- 需要进一步的调查来证实这一关联.
- 建议在接受达沙替尼的CML患者中仔细监测STSS症状.
更多相关视频
09:15Author Spotlight: Optimized Protocol for Detecting Antigen-Specific T Cells in Mouse Lungs Using Tetramers
Published on: July 19, 2024
1.6K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.7K
相关概念视频
Acute Kidney Injury III: Clinical Manifestations
802
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
802
Rheumatic Heart Disease I: Introduction
417
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
417
Acute Kidney Injury II: Pathophysiology
869
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
869
Nephrotic Syndrome I : Introduction
486
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
486
Acute Kidney Injury I: Introduction
554
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
554
Renal Failure: Dose Adjustments
426
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
426
